Data as of Jan 23
| -0.084 / -10.50%|
The 1 analysts offering 12-month price forecasts for CollabRx Inc have a median target of 1.85, with a high estimate of 1.85 and a low estimate of 1.85. The median estimate represents a +158.42% increase from the last price of 0.72.
The current consensus among 1 polled investment analysts is to Buy stock in CollabRx Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.